ZYVERSA THERAPEUTICS, INC. Earnings Per Share (Basic)
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Earnings Per Share (Basic) of -$0.22 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-05-13
- ZYVERSA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.22.
- ZYVERSA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$2.56.
- ZYVERSA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.46.
- ZYVERSA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-03-31 was -$0.73.
- ZYVERSA THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$4.18.
- ZYVERSA THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$8.48.
- ZYVERSA THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$1089.70.
| Period end | Earnings Per Share, Basic 1 month | Earnings Per Share, Basic 1 month as first filed | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 11 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$0.22 10-Q · filed 2026-05-13 | ||||||||||
| 2025-12-31 | -$4.18 10-K · filed 2026-03-31 | ||||||||||
| 2025-09-30 | -$2.56 10-Q · filed 2025-11-19 | -$4.63 10-Q · filed 2025-11-19 | |||||||||
| 2025-06-30 | -$0.46 10-Q · filed 2025-08-13 | -$1.13 10-Q · filed 2025-08-13 | |||||||||
| 2025-03-31 | -$0.73 10-Q · filed 2026-05-13 | ||||||||||
| 2024-12-31 | -$0.71 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$2.57 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$5.18 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$8.48 10-K · filed 2026-03-31 | |||||||
| 2024-09-30 | -$2.43 10-Q · filed 2025-11-19 | -$5.67 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$9.79 10-Q · filed 2025-11-19 | -$32.05 derived: net income ÷ weighted average shares · filed 2025-11-19 | |||||||
| 2024-06-30 | -$3.31 10-Q · filed 2025-08-13 | -$7.67 10-Q · filed 2025-08-13 | -$33.94 derived: net income ÷ weighted average shares · filed 2025-08-13 | -$49.39 derived: net income ÷ weighted average shares · filed 2025-08-13 | |||||||
| 2024-03-31 | -$4.53 10-Q · filed 2025-05-12 | -$38.56 derived: net income ÷ weighted average shares · filed 2025-05-12 | -$61.24 derived: net income ÷ weighted average shares · filed 2025-05-12 | -$427.79 derived: net income ÷ weighted average shares · filed 2025-05-12 | |||||||
| 2023-12-31 | -$62.08 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$104.28 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$848.47 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$1089.70 10-K · filed 2025-03-27 | -$108.97 10-K · filed 2024-03-25 | ||||||
| 2023-09-30 | -$30.18 10-Q · filed 2024-11-14 | -$0.09 10-Q · filed 2023-11-14 | -$1205.43 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$1591.46 10-Q · filed 2024-11-14 | -$4.79 10-Q · filed 2023-11-14 | ||||||
| 2023-06-30 | -$1694.12 10-Q · filed 2024-08-09 | -$4.84 10-Q · filed 2023-08-21 | -$2329.76 10-Q · filed 2024-08-09 | -$6.66 10-Q · filed 2023-08-21 | |||||||
| 2023-03-31 | -$135.88 10-Q · filed 2024-05-15 | -$0.39 10-Q · filed 2023-05-12 | |||||||||
| 2022-12-31 | -$0.29 10-K · filed 2024-03-25 | -$0.01 10-K · filed 2023-03-31 | |||||||||
| 2022-12-12 | -$0.99 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |